Roberto Arnaldo Calle

Title: The Innovations of Roberto Arnaldo Calle

Introduction

Roberto Arnaldo Calle is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. His innovative approach has led to the development of a unique method for addressing fatty liver disease and related disorders.

Latest Patents

Calle holds a patent for "Combinations for treatment of NAFLD/NASH and related diseases." This patent describes a method for treating fatty liver disease with a therapeutically effective amount of a specific composition. The composition includes from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, along with from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof. This patent highlights his commitment to advancing medical treatments.

Career Highlights

Calle is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to collaborate with other talented professionals in the field. His dedication to research and innovation has positioned him as a key figure in the development of new therapeutic methods.

Collaborations

Throughout his career, Calle has worked alongside esteemed colleagues such as Neeta Balkrishan Amin and Arthur James Bergman. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Roberto Arnaldo Calle's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in the treatment of liver diseases.